Výsledky vyhledávání - "Anders Uddevik"

Akademický článek

Temporary cessation of ibrutinib results in reduced grade 3‐4 infections and durable remissions—Interim analysis of an on‐off‐repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia

Autor: Jeanette Lundin, Tom A. Mulder, Magdalena Kättström, Tove Wästerlid, Anders Uddevik, Håkan Mellstedt, Kia Heimersson, Lotta Hansson, Marzia Palma, Anders Österborg

Publikováno v: eJHaem, Vol 2, Iss 3, Pp 525-529 (2021)

Abstract Ibrutinib is used continuously in CLL. This phase 1b/2 study interim analysis explored on‐off‐repeat dosing to reduce toxicity. After 12 months, 16/22 patients (73%) remained in first off‐phase irrespective if initial CR/PR or TP53 abe

Externí odkaz: https://doaj.org/article/7f328d6a737444259549a86a1865a7f1

Zobrazit plný text záznamu

Autor: Tom A. Mulder, Tove Wästerlid, Anders Österborg, Kia Heimersson, Marzia Palma, Håkan Mellstedt, Lotta Hansson, Magdalena Kättström, Anders Uddevik, Jeanette Lundin

Publikováno v: eJHaem. 2:525-529

Ibrutinib is used continuously in CLL. This phase 1b/2 study interim analysis explored on-off-repeat dosing to reduce toxicity. After 12 months, 16/22 patients (73%) remained in first off-phase irrespective if initial CR/PR or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15be6057c8d8e18fed3317b3f5ff0b45
https://doi.org/10.1002/jha2.261

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání